Compare PTCT & VOYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PTCT | VOYA |
|---|---|---|
| Founded | 1998 | 1975 |
| Country | United States | United States |
| Employees | N/A | 11000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Life Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 6.2B |
| IPO Year | 2006 | N/A |
| Metric | PTCT | VOYA |
|---|---|---|
| Price | $69.14 | $68.13 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 9 |
| Target Price | $80.65 | ★ $87.33 |
| AVG Volume (30 Days) | ★ 915.0K | 859.5K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 2.80% |
| EPS Growth | ★ 264.48 | N/A |
| EPS | ★ 7.78 | N/A |
| Revenue | ★ $264,734,000.00 | N/A |
| Revenue This Year | N/A | $4.27 |
| Revenue Next Year | $19.30 | $4.98 |
| P/E Ratio | ★ $8.71 | $12.00 |
| Revenue Growth | ★ 36.19 | N/A |
| 52 Week Low | $35.95 | $52.69 |
| 52 Week High | $87.50 | $79.99 |
| Indicator | PTCT | VOYA |
|---|---|---|
| Relative Strength Index (RSI) | 55.26 | 48.78 |
| Support Level | $64.00 | $65.17 |
| Resistance Level | $69.23 | $69.55 |
| Average True Range (ATR) | 2.24 | 2.02 |
| MACD | 0.57 | 0.27 |
| Stochastic Oscillator | 81.53 | 63.44 |
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
Voya Financial Inc is a financial services company, which, through its subsidiaries, provides various investment, insurance, and retirement solutions to individual and institutional clients in the United States. Its products and services include tax savings plans, individual retirement accounts, group life insurance plans, and employee benefits products, among others. The company tailors each of its products to the needs of its customer base. It operates its business through three principal lines: Retirement, Investment Management and Employee Benefits.The majority revenue is from Retirement segment.